Cargando…

P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY

Detalles Bibliográficos
Autores principales: Salmanton-García, Jon, Marchesi, Francesco, Weinbergerová, Barbora, Buquicchio, Caterina, Čolović, Natasa, Praet, Jens VAN, Koehler, Philipp, Falces-Romero, Iker, Farina, Francesca, Itri, Federico, Romano, Alessandra, Pagano, Livio, Cornely, Oliver A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430161/
http://dx.doi.org/10.1097/01.HS9.0000972936.16284.b9
_version_ 1785090889711878144
author Salmanton-García, Jon
Marchesi, Francesco
Weinbergerová, Barbora
Buquicchio, Caterina
Čolović, Natasa
Praet, Jens VAN
Koehler, Philipp
Falces-Romero, Iker
Farina, Francesca
Itri, Federico
Romano, Alessandra
Pagano, Livio
Cornely, Oliver A.
author_facet Salmanton-García, Jon
Marchesi, Francesco
Weinbergerová, Barbora
Buquicchio, Caterina
Čolović, Natasa
Praet, Jens VAN
Koehler, Philipp
Falces-Romero, Iker
Farina, Francesca
Itri, Federico
Romano, Alessandra
Pagano, Livio
Cornely, Oliver A.
author_sort Salmanton-García, Jon
collection PubMed
description
format Online
Article
Text
id pubmed-10430161
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104301612023-08-17 P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY Salmanton-García, Jon Marchesi, Francesco Weinbergerová, Barbora Buquicchio, Caterina Čolović, Natasa Praet, Jens VAN Koehler, Philipp Falces-Romero, Iker Farina, Francesca Itri, Federico Romano, Alessandra Pagano, Livio Cornely, Oliver A. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430161/ http://dx.doi.org/10.1097/01.HS9.0000972936.16284.b9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Salmanton-García, Jon
Marchesi, Francesco
Weinbergerová, Barbora
Buquicchio, Caterina
Čolović, Natasa
Praet, Jens VAN
Koehler, Philipp
Falces-Romero, Iker
Farina, Francesca
Itri, Federico
Romano, Alessandra
Pagano, Livio
Cornely, Oliver A.
P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
title P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
title_full P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
title_fullStr P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
title_full_unstemmed P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
title_short P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
title_sort p1514: molnupiravir compared to nirmatrelvir/ritonavir for covid-19 in high-risk patients with haematological malignancy in europe. a matched-paired analysis from the epicovideha registry
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430161/
http://dx.doi.org/10.1097/01.HS9.0000972936.16284.b9
work_keys_str_mv AT salmantongarciajon p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT marchesifrancesco p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT weinbergerovabarbora p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT buquicchiocaterina p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT colovicnatasa p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT praetjensvan p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT koehlerphilipp p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT falcesromeroiker p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT farinafrancesca p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT itrifederico p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT romanoalessandra p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT paganolivio p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry
AT cornelyolivera p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry